Reginster, Jean-Yves
Hattersley, Gary
Williams, Gregory C.
Hu, Ming-yi
Fitzpatrick, Lorraine A.
Lewiecki, E. Michael
Funding for this research was provided by:
Radius Health, Inc.
Article History
Received: 16 May 2018
Accepted: 22 June 2018
First Online: 27 June 2018
Compliance with Ethical Standards
:
: Jean-Yves Reginster reports consulting fees or paid advisory boards from IBSA-Genevrier, Mylan, Pierre Fabre, and Radius Health, Inc.; lecture fees when speaking at the invitation of the following sponsors: IBSA-Genevrier, Mylan, CNIEL, Dairy Research Council (DRC); and grant support from industry (all through his institution) from: IBSA-Genevrier, Mylan, CNIEL, and Radius Health, Inc. Gary Hattersley, Gregory C. Williams, Ming-yi Hu, and Lorraine A. Fitzpatrick are employees of Radius Health, Inc. and own stock in Radius Health, Inc. E. Michael Lewiecki has received institutional grant/research support from Amgen, PFEnex, and Mereo; has served on scientific advisory boards for Amgen, Radius Health, Inc., Shire, Alexion, Ultragenyx, and Sandoz; and serves on the speakers’ bureau for Shire, Alexion, and Radius Health, Inc.
: Participants in the phase 3 ACTIVE study provided written informed consent, and the protocol was approved by the respective institutional review boards.